Galecto, Inc. (GLTO) Financials

GLTO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 38.2 million 5.9 million
2023-09-30 50.0 million 12.7 million
2023-06-30 58.8 million 15.1 million
2023-03-31 64.6 million 14.3 million

GLTO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -11.5 million 1.1 million
2023-09-30 -8.5 million 1.5 million
2023-06-30 -7.8 million 1.4 million
2023-03-31 -9.1 million 1.4 million

GLTO Net Income

No data available :(

GLTO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 33.2 million - 249000
2023-09-30 44.2 million - 464000
2023-06-30 52.1 million - 626000
2023-03-31 53.2 million - 686000

GLTO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 27.1 million
2023-09-30 27.1 million
2023-06-30 26.4 million
2023-03-31 25.7 million

GLTO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.8 million 3.2 million 229000
2023-09-30 - 2.6 million 3.3 million -
2023-06-30 - 8.1 million 3.1 million -
2023-03-31 - 10.4 million 3.1 million -

GLTO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.2 million 229000
2023-09-30 - 367000
2023-06-30 - 95000
2023-03-31 - 139000

GLTO

Price: $0.72

52 week price:
0.50
3.70

Earnings Per Share: -1.44 USD

P/E Ratio: -0.38

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 27417

Market Capitalization: 18.6 million

Links: